Thomas Steger‐Hartmann

3.8k total citations · 1 hit paper
58 papers, 2.4k citations indexed

About

Thomas Steger‐Hartmann is a scholar working on Computational Theory and Mathematics, Small Animals and Molecular Biology. According to data from OpenAlex, Thomas Steger‐Hartmann has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Computational Theory and Mathematics, 15 papers in Small Animals and 9 papers in Molecular Biology. Recurrent topics in Thomas Steger‐Hartmann's work include Computational Drug Discovery Methods (16 papers), Animal testing and alternatives (15 papers) and Lanthanide and Transition Metal Complexes (7 papers). Thomas Steger‐Hartmann is often cited by papers focused on Computational Drug Discovery Methods (16 papers), Animal testing and alternatives (15 papers) and Lanthanide and Transition Metal Complexes (7 papers). Thomas Steger‐Hartmann collaborates with scholars based in Germany, Switzerland and United States. Thomas Steger‐Hartmann's co-authors include Klaus Kümmerer, R. Länge, Hermann Schweinfurth, Matthew Clark, Michael Meyer, Andreas Hartmann, Hubertus Pietsch, Martin A. Sieber, Nikolaus Heinrich and Andreas Sutter and has published in prestigious journals such as Water Research, Nature Reviews Drug Discovery and Advanced Drug Delivery Reviews.

In The Last Decade

Thomas Steger‐Hartmann

55 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving role of investigative toxicology in the pharmaceutical industry

2023 132 citations Mario Beilmann, Harrie C. M. Boonen et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Thomas Steger‐Hartmann

Since Specialization

Citations

This map shows the geographic impact of Thomas Steger‐Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Steger‐Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Steger‐Hartmann more than expected).

Fields of papers citing papers by Thomas Steger‐Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Steger‐Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Steger‐Hartmann. The network helps show where Thomas Steger‐Hartmann may publish in the future.

Co-authorship network of co-authors of Thomas Steger‐Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Steger‐Hartmann. A scholar is included among the top collaborators of Thomas Steger‐Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Steger‐Hartmann. Thomas Steger‐Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Application of new approach methodologies for nonclinical safety assessment of drug candidates	Nature Reviews Drug Discovery	Mario Beilmann, Karissa Adkins et al.	7
2	Replacing concurrent controls with virtual control groups in rat toxicity studies	Regulatory Toxicology and Pharmacology	Carlos H. Vieira-Vieira, Lea Vaas et al.	10
3	Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis	Drugs in R&D	Jan Hilpert, Laura Bennett et al.	10
4	Perspectives of data science in preclinical safety assessment	Drug Discovery Today	Thomas Steger‐Hartmann, Annika Kreuchwig et al.	7
5	Hurdles and signposts on the road to virtual control groups—A case study illustrating the influence of anesthesia protocols on electrolyte levels in rats	Frontiers in Pharmacology	Thomas Steger‐Hartmann, Lea Vaas et al.	11
6	Translating in vitro to in vivo and animal to human	Current Opinion in Toxicology	Thomas Steger‐Hartmann, Marian Raschke	17
7	Making reliable negative predictions of human skin sensitisation using an in silico fragmentation approach	Regulatory Toxicology and Pharmacology	Donna S. Macmillan, Thomas Steger‐Hartmann et al.	19
8	Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture model	Scientific Reports	Marian Raschke, Tobias Hasenberg et al.	64
9	The Future of Stem Cells and Toxicity Screening		Thomas Steger‐Hartmann, Bruce K. Young et al.	1
10	Value of shared preclinical safety studies – The eTOX database	Toxicology Reports	Katharine Briggs, Chris Barber et al.	18
11	Toxicological Safety Evaluation of Gadobutrol	Investigative Radiology	Thomas Steger‐Hartmann et al.	21
12	Incorporation of in silico biodegradability screening in early drug development—a feasible approach?	Environmental Science and Pollution Research	Thomas Steger‐Hartmann, R. Länge et al.	6
13	Evaluating the role of zinc in the occurrence of fibrosis of the skin: A preclinical study	Journal of Magnetic Resonance Imaging	Hubertus Pietsch, Philipp Lengsfeld et al.	18
14	The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process	Regulatory Toxicology and Pharmacology	Thomas Steger‐Hartmann, Hermann Schweinfurth et al.	11
15	Towards the creation of an international toxicology information centre	Toxicology	Philip N. Judson, Paul Cooke et al.	37
16	Morphological sex reversal upon short-term exposure to endocrine modulators in juvenile fathead minnow (Pimephales promelas)	Toxicology Letters	R. Länge, Thomas Steger‐Hartmann et al.	71
17	Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium	Water Research	Thomas Steger‐Hartmann, R. Länge et al.	63
18	Specific Detection of Membrane-Toxic Substances with a Conductivity Assay	Ecotoxicology and Environmental Safety	Thomas Steger‐Hartmann, Edgar Wagner et al.	11
19	Environmental Risk Assessment for the Widely Used Iodinated X-Ray Contrast Agent Iopromide (Ultravist)	Ecotoxicology and Environmental Safety	Thomas Steger‐Hartmann, R. Länge et al.	127
20	Biological Degradation of Cyclophosphamide and Its Occurrence in Sewage Water	Ecotoxicology and Environmental Safety	Thomas Steger‐Hartmann, Klaus Kümmerer et al.	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact